Venovenøs hæmodiafiltrering til baclofenforgiftet patient

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Standard

Venovenøs hæmodiafiltrering til baclofenforgiftet patient. / Nielsen, Simon Uhl; Jansen, Tejs; Johansen, Sys Stybe; Linnet, Kristian; Gregersen, Peter; Høgberg, Lotte Christine Groth.

I: Ugeskrift for Laeger, Bind 173, Nr. 22, 2011, s. 1578-9.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Harvard

Nielsen, SU, Jansen, T, Johansen, SS, Linnet, K, Gregersen, P & Høgberg, LCG 2011, 'Venovenøs hæmodiafiltrering til baclofenforgiftet patient', Ugeskrift for Laeger, bind 173, nr. 22, s. 1578-9.

APA

Nielsen, S. U., Jansen, T., Johansen, S. S., Linnet, K., Gregersen, P., & Høgberg, L. C. G. (2011). Venovenøs hæmodiafiltrering til baclofenforgiftet patient. Ugeskrift for Laeger, 173(22), 1578-9.

Vancouver

Nielsen SU, Jansen T, Johansen SS, Linnet K, Gregersen P, Høgberg LCG. Venovenøs hæmodiafiltrering til baclofenforgiftet patient. Ugeskrift for Laeger. 2011;173(22):1578-9.

Author

Nielsen, Simon Uhl ; Jansen, Tejs ; Johansen, Sys Stybe ; Linnet, Kristian ; Gregersen, Peter ; Høgberg, Lotte Christine Groth. / Venovenøs hæmodiafiltrering til baclofenforgiftet patient. I: Ugeskrift for Laeger. 2011 ; Bind 173, Nr. 22. s. 1578-9.

Bibtex

@article{d2cda7cf126343b38e9ee72c578906de,
title = "Venoven{\o}s h{\ae}modiafiltrering til baclofenforgiftet patient",
abstract = "Twice a young man was admitted to hospital upon having taken baclofen overdoses by intention. The ingested dose was 1,850 mg at the first episode and up to 2,500 mg at the second. In both cases the patient had severe overdose symptoms and scored 4-5 on the Glascow Coma Scale and was admitted to intensive care. Continuous venovenous hemodiafiltration (CVVHDF) was initiated. The elimination pharmacokinetics and toxicokinetics for baclofen is not fully known. During the second submission a shorter elimination half-life time was observed and it might be due to either compartmental distribution of baclofen, or more likely caused by an advantageous effect of the CVVHDF.",
keywords = "Baclofen, Drug Overdose, Half-Life, Hemofiltration, Humans, Male, Muscle Relaxants, Central, Suicide, Attempted, Young Adult",
author = "Nielsen, {Simon Uhl} and Tejs Jansen and Johansen, {Sys Stybe} and Kristian Linnet and Peter Gregersen and H{\o}gberg, {Lotte Christine Groth}",
year = "2011",
language = "Dansk",
volume = "173",
pages = "1578--9",
journal = "Ugeskrift for Laeger",
issn = "0041-5782",
publisher = "Almindelige Danske Laegeforening",
number = "22",

}

RIS

TY - JOUR

T1 - Venovenøs hæmodiafiltrering til baclofenforgiftet patient

AU - Nielsen, Simon Uhl

AU - Jansen, Tejs

AU - Johansen, Sys Stybe

AU - Linnet, Kristian

AU - Gregersen, Peter

AU - Høgberg, Lotte Christine Groth

PY - 2011

Y1 - 2011

N2 - Twice a young man was admitted to hospital upon having taken baclofen overdoses by intention. The ingested dose was 1,850 mg at the first episode and up to 2,500 mg at the second. In both cases the patient had severe overdose symptoms and scored 4-5 on the Glascow Coma Scale and was admitted to intensive care. Continuous venovenous hemodiafiltration (CVVHDF) was initiated. The elimination pharmacokinetics and toxicokinetics for baclofen is not fully known. During the second submission a shorter elimination half-life time was observed and it might be due to either compartmental distribution of baclofen, or more likely caused by an advantageous effect of the CVVHDF.

AB - Twice a young man was admitted to hospital upon having taken baclofen overdoses by intention. The ingested dose was 1,850 mg at the first episode and up to 2,500 mg at the second. In both cases the patient had severe overdose symptoms and scored 4-5 on the Glascow Coma Scale and was admitted to intensive care. Continuous venovenous hemodiafiltration (CVVHDF) was initiated. The elimination pharmacokinetics and toxicokinetics for baclofen is not fully known. During the second submission a shorter elimination half-life time was observed and it might be due to either compartmental distribution of baclofen, or more likely caused by an advantageous effect of the CVVHDF.

KW - Baclofen

KW - Drug Overdose

KW - Half-Life

KW - Hemofiltration

KW - Humans

KW - Male

KW - Muscle Relaxants, Central

KW - Suicide, Attempted

KW - Young Adult

M3 - Tidsskriftartikel

C2 - 21627904

VL - 173

SP - 1578

EP - 1579

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

SN - 0041-5782

IS - 22

ER -

ID: 33692377